Cargando…
Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study
The present study aims to analyze the clinical and socio-demographic characteristics of patients with obsessive-compulsive disorder (OCD) in comorbidity with schizotypal personality disorder (SPD), as well as the response rate to pharmacological treatments. OCD+SPD patients had a younger age at onse...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589899/ https://www.ncbi.nlm.nih.gov/pubmed/31263430 http://dx.doi.org/10.3389/fpsyt.2019.00386 |
_version_ | 1783429449726820352 |
---|---|
author | Perris, Francesco Fabrazzo, Michele De Santis, Valeria Luciano, Mario Sampogna, Gaia Fiorillo, Andrea Catapano, Francesco |
author_facet | Perris, Francesco Fabrazzo, Michele De Santis, Valeria Luciano, Mario Sampogna, Gaia Fiorillo, Andrea Catapano, Francesco |
author_sort | Perris, Francesco |
collection | PubMed |
description | The present study aims to analyze the clinical and socio-demographic characteristics of patients with obsessive-compulsive disorder (OCD) in comorbidity with schizotypal personality disorder (SPD), as well as the response rate to pharmacological treatments. OCD+SPD patients had a younger age at onset, a higher probability to have more severe obsessive-compulsive symptoms, a higher rate of schizophrenia spectrum disorders in their first-degree relatives, and a poorer insight compared to OCD patients. During the 3-year follow-up period, these patients showed a lower rate of recovery, thus requiring augmentation with different psychotropic medications, including low doses of antipsychotics. Our findings suggest that the comorbidity of OCD and SPD causes a poor treatment response, and a reduced probability to recover using standard pharmacological treatment strategies. Further investigations are needed to identify alternative strategies, including psychoeducation and cognitive behavioral therapy, to manage such frequent comorbidity in clinical practice. |
format | Online Article Text |
id | pubmed-6589899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65898992019-07-01 Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study Perris, Francesco Fabrazzo, Michele De Santis, Valeria Luciano, Mario Sampogna, Gaia Fiorillo, Andrea Catapano, Francesco Front Psychiatry Psychiatry The present study aims to analyze the clinical and socio-demographic characteristics of patients with obsessive-compulsive disorder (OCD) in comorbidity with schizotypal personality disorder (SPD), as well as the response rate to pharmacological treatments. OCD+SPD patients had a younger age at onset, a higher probability to have more severe obsessive-compulsive symptoms, a higher rate of schizophrenia spectrum disorders in their first-degree relatives, and a poorer insight compared to OCD patients. During the 3-year follow-up period, these patients showed a lower rate of recovery, thus requiring augmentation with different psychotropic medications, including low doses of antipsychotics. Our findings suggest that the comorbidity of OCD and SPD causes a poor treatment response, and a reduced probability to recover using standard pharmacological treatment strategies. Further investigations are needed to identify alternative strategies, including psychoeducation and cognitive behavioral therapy, to manage such frequent comorbidity in clinical practice. Frontiers Media S.A. 2019-06-17 /pmc/articles/PMC6589899/ /pubmed/31263430 http://dx.doi.org/10.3389/fpsyt.2019.00386 Text en Copyright © 2019 Perris, Fabrazzo, De Santis, Luciano, Sampogna, Fiorillo and Catapano http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Perris, Francesco Fabrazzo, Michele De Santis, Valeria Luciano, Mario Sampogna, Gaia Fiorillo, Andrea Catapano, Francesco Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study |
title | Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study |
title_full | Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study |
title_fullStr | Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study |
title_full_unstemmed | Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study |
title_short | Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study |
title_sort | comorbidity of obsessive-compulsive disorder and schizotypal personality disorder: clinical response and treatment resistance to pharmacotherapy in a 3-year follow-up naturalistic study |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589899/ https://www.ncbi.nlm.nih.gov/pubmed/31263430 http://dx.doi.org/10.3389/fpsyt.2019.00386 |
work_keys_str_mv | AT perrisfrancesco comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy AT fabrazzomichele comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy AT desantisvaleria comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy AT lucianomario comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy AT sampognagaia comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy AT fiorilloandrea comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy AT catapanofrancesco comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy |